Narendiran Rajasekaran
Overview
Explore the profile of Narendiran Rajasekaran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Rajasekaran N, Solomon S, Watanabe T, Ohtsu H, Gajda M, Brauer R, et al.
Int Immunol
. 2009 Sep;
21(11):1263-8.
PMID: 19762454
Serum transfer from arthritic K/BxN mice into naive animals results in arthritis. Mast cells have been shown to be essential since mice lacking these cell type do not develop arthritis...
22.
Masilamani M, Rajasekaran N, Singh A, Low H, Albus K, Anders S, et al.
Rheumatol Int
. 2008 May;
28(11):1137-41.
PMID: 18500464
Complement receptor type II/CD21 is the functional receptor for complement fragments such as C3d, iC3b and the Epstein Barr Virus. A soluble form of CD21 (sCD21) is shed from lymphocytes...
23.
Spohn G, Schwarz K, Maurer P, Illges H, Rajasekaran N, Choi Y, et al.
J Immunol
. 2005 Oct;
175(9):6211-8.
PMID: 16237119
TNF-related activation-induced cytokine (TRANCE), also known as receptor activator of NF-kappaB ligand (RANKL), is the key molecule responsible for the bone loss observed in osteoporosis. Passive administration of osteoprotegerin, the...
24.
Solomon S, Rajasekaran N, Jeisy-Walder E, Snapper S, Illges H
Eur J Immunol
. 2005 Sep;
35(10):3064-73.
PMID: 16180250
Autoantibodies in the form of immune complexes are known to be crucial mediators in initiating inflammation in a variety of autoimmune diseases. This has been well documented in the anti-collagen...